Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 30, Number 1—January 2024

CME ACTIVITY - Research

Early-Onset Infection Caused by Escherichia coli Sequence Type 1193 in Late Preterm and Full-Term Neonates

Célie Malaure1, Guillaume Geslain1, André Birgy, Philippe Bidet, Isabelle Poilane, Margaux Allain, Mathilde Liberge, Nizar Khattat, Paola Sikias, and Stéphane BonacorsiComments to Author 
Author affiliations: Escherichia coli National Reference Center, Robert-Debré University Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France (C. Malaure, A. Birgy, P. Bidet, S. Bonacorsi); Paediatric Intensive Care Unit, Robert-Debré University Hospital, Assistance Publique–Hôpitaux de Paris, Paris (G. Geslain); Paris Cité University, Paris (G. Geslain, A. Birgy, P. Bidet, S. Bonacorsi); Avicenne University Hospital, Assistance Publique–Hôpitaux de Paris, Bobigny, France (I. Poilane); Louis Mourier University Hospital, Assistance Publique–Hôpitaux de Paris, Colombes, France (M. Allain); Saint Louis University Hospital, Assistance Publique–Hôpitaux de Paris, Paris (M. Liberge); Neonatal Care Unit, Robert-Debré University Hospital, Assistance Publique–Hôpitaux de Paris, Paris (N. Khattat); Hôpital Privé d'Antony, Ramsay Santé, Antony, France (P. Sikias)

Main Article

Table 1

Characteristics of mothers and their newborns with early-onset sepsis caused by Escherichia coli strains, France*

Case ID Birth city† Pregnancy term, wk Prepartum antimicrobial‡ Meningitis§ Serotypes¶ FimH type ST (STc)# ESBL
APIMF52
Pontoise
37
–
–
O18:K1
fimH15
95
–
APIMF53
Antony
38
–
–
O13:K1
fimH21
357
–
APIMF54
Paris (Robert Debre)
35
+
–
O7:K5
fimH27
93 (168)
–
APIMF56
Orsay
41
+
–
O84
fimH38
2040
–
APIMF57
Clamart
40
+
–
O8
fimH32
58 (155)
–
APIMF58
Clichy
36
+
–
O18:K5
fimH27
14
–
APIMF59
Paris (Necker)
36
–
–
O25:K5
fimH30
131
+
APIMF60
Paris (Clinique Bleuets)
37
+
+
O75:K1
fimH64
1193 (14)
+
APIMF63
Quincy Sous Senart
39
–
–
O2:K1
fimH34
10
–
APIMF67
Mantes-La-Jolie
39
–
–
O18:K1
fimH107
95
–
APIMF68
Paris (Pitie)
40
–
–
O2:K1
fimH27
95
–
APIMF69
Saint Cloud
35
–
–
O18:K1
fimH15
95
–
APIMF70
Saint Denis
40
–
–
O25:K1
fimH41
59
–
APIMF71
Paris (Trousseau)
37
–
–
O7:K1
fimH1
80 (568)
–
APIMF72
Aulnay
36
–
–
O1:K1
fimH41
95
–
APIMF73
Villeneuve Saint-Georges
34
+
–
O75:K1
fimH64
1193 (14)
+
APIMF76
Colombes
41
–
–
O75:K1
fimH64
1193 (14)
–
APIMF77
Nogent Sur Marne
41
–
–
O17/O77:K52
Unknown
394
–
APIMF78
Coulommiers
41
–
+
O75:K1
fimH64
1193 (14)
–
APIMF79
Longjumeau
38
–
–
O6:K23
fimH103
73
–
APIMF80
Eaubonne
38
–
–
O4:K96
fimH5
12
–
APIMF81
Jossigny
34
–
–
O75:K5
fimH27
14
–
APIMF82
Meaux
34
+
–
O25:K5
fimH28
2279 (131)
–
APIMF83
Saint-Maurice
39
+
–
O8
fimH29
58 (155)
–
APIMF84
Creteil
39
+
–
O15:K96
fimH30
69
–
APIMF85
Arpajon
41
–
–
O4:Ku
fimH8–like
12
–
APIMF87
Paris (Trousseau)
35
–
+
O7:K1
fimH44
62
–
APIMF88
Marne La Vallee
36
+
+
O7:K1
fimH44
62
–
APIMF89
Creteil
36
+
+
O75:K1
fimH64
1193 (14)
+
APIMF90
Levallois Perret
36
+
–
O75:K1
fimH64
1193 (14)
–
APIMF91
Melun
34
–
–
O1:K1
fimH41
59
–
APIMF92 Beaumont Sur Oise 40 + + O18:K1 fimH15 95 –

*ESBL, extended spectrum β-lactamase; FimH, type 1 fimbriae D-mannose specific adhesin; ID, identification;Ku, unknown serogroup capsular; +, positive for condition; –, negative for condition. †For Paris birthplaces, name of hospital where born is indicated in parentheses. ‡Amoxicillin was the only antimicrobial prescribed within 3 days before labor. §Early onset neonatal meningitis. ¶O antigen predicted with SerotypeFinder 2.0 and serogroup capsular predicted by the Center for Genomic Epidemiology (https://genomicepidemiology.org). #Sequence type complex (STc) indicated in parentheses if different from ST number.

Main Article

1These authors contributed equally to this manuscript.

Page created: November 08, 2023
Page updated: December 21, 2023
Page reviewed: December 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external